文献速递艾滋病与性传播感染

极早期治疗婴儿中细胞相关HIV-1 DNA的预测因素:一项超过1年的研究

Predictors of Cell-Associated Human Immunodeficiency Virus (HIV)-1 DNA Over 1 Year in Very Early Treated Infants.
PubMed 文献 · Clin Infect Dis · 2022-01-01

分析发现,治疗前CD4+ T细胞百分比更高、病毒载量<100 000 copies/mL、无产前母体ART及母乳喂养与更低vDNA相关;启动ART年龄>14天有负面影响。

要点

  • 治疗前CD4+百分比高和病毒载量<100 000 copies/mL与48周内更低HIV-1 DNA相关
  • 无产前母体ART和母乳喂养也与更低vDNA相关
  • 启动ART年龄>14天可观察到负面影响

核心结论

  • 在极早期治疗的婴儿中,治疗前CD4+ T细胞百分比更高、病毒载量<100 000 copies/mL、无产前母体ART及母乳喂养与治疗48周内更低HIV-1 DNA水平相关。
  • 启动ART年龄>14天有可辨别的负面影响。

研究设计与样本

  • 定期采集至48周的外周血单核细胞及入组时母体样本,用整合酶靶向半巢式实时定量TaqMan PCR定量总HIV-1 C亚型DNA。
  • 采用广义估计方程回归分析预测因素。

主要发现

  • 31名(49.2%)在出生<48小时内启动ART,24名(38.1%)<14天,8名(12.7%)>14天。
  • 四分之三婴儿尽管有母体产前ART仍感染(但仅9.5%女性在最近分娩时病毒载量检测不到),86%接受母乳喂养。
  • 治疗前婴儿CD4+ T细胞百分比更高和病毒载量<100 000 copies/mL与ART启动后48周内更低vDNA相关。
  • 无产前母体ART和母乳喂养也与更低vDNA相关。
  • 启动ART年龄>14天时有可辨别的负面影响。

临床怎么用

  • 对于极早期治疗的HIV-1感染婴儿,可关注治疗前CD4+百分比和病毒载量以评估病毒库水平。
  • 启动ART年龄>14天可能对病毒库有负面影响,应尽早启动治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Younger age of antiretroviral therapy (ART) initiation is associated with smaller viral reservoirs in perinatally acquired HIV-1 infection, but there is wide variability among early-treated infants. Predictors of this variability are not fully described. METHODS: Sixty-three neonates diagnosed with HIV-1 <48 hours after birth in Johannesburg, South Africa, were started on ART as soon as possible. Fifty-nine (94%) infants received nevirapine prophylaxis from birth until ART start. Viably preserved peripheral blood mononuclear cells (PBMCs) collected at regular intervals to 48 weeks, and from mothers at enrollment, were tested using integrase-targeted, semi-nested, real-time quantitative hydrolysis probe (TaqMan) PCR assays to quantify total HIV-1 subtype C viral DNA (vDNA). Predictors were investigated using generalized estimating equation regression. RESULTS: Thirty-one (49.2%) infants initiated ART <48 hours, 24 (38.1%) <14 days, and 8 (12.7%) >14 days of birth. Three-quarters were infected despite maternal antenatal ART (however, only 9.5% of women had undetectable viral load closest to delivery) and 86% were breastfed. Higher infant CD4+ T-cell percentage and viral load <100 000 copies/mL pre-ART were associated with lower vDNA in the first 48 weeks after ART start. No antenatal maternal ART and breastfeeding were also associated with lower vDNA. Older age at ART initiation had a discernible negative impact when initiated >14 days. CONCLUSIONS: Among very early treated infants, higher CD4+ T-cell percentage and viral load <100 000 copies/mL pre-ART, infection occurring in the absence of maternal antenatal ART, and breastfeeding were associated with lower levels of HIV-1 DNA in the first 48 weeks of treatment. Clinical Trials Registration. clinicaltrials.gov (NCT02431975).

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Kuhn L, Paximadis M, Da Costa Dias B, et al. Predictors of Cell-Associated Human Immunodeficiency Virus (HIV)-1 DNA Over 1 Year in Very Early Treated Infants. Clin Infect Dis. 2022. PMID: 34185838. doi:10.1093/cid/ciab586

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。